Liu Binlei is the founder of Binhui Biotech. Binhui Biotech has raised $537M in total funding. Latest round: Series B. Based in Wuhan, China.
Liu Binlei founded Binhui Biopharm in 2010, leveraging his 20 years of research experience in oncolytic viruses. He was the chief scientist of molecular biology at Boivex in the UK and a key member in developing the first FDA-approved oncolytic virus drug T-VEC. After returning to China, he led a team to develop the tumor immunotherapy drug "Oncolytic Type II Herpes Simplex Virus".
Full founder directory · Investor directory · Company funding database · Fundraising library